How to access Oxlumo from the UAE, the named-patient import pathway, 2026
By Reserve Meds · Clinical & regulatory team · Last reviewed 2026-04-23
An Emirati patient, paediatric or adult, diagnosed with primary hyperoxaluria type 1 (PH1) may receive a prescription for Oxlumo (lumasiran) from their treating nephrologist or metabolic-disease specialist. Oxlumo is FDA-approved for PH1 across all ages and is developed by Alnylam Pharmaceuticals. PH1 is ultra-rare, and routine stocking through the UAE hospital pharmacies is inconsistent, so access typically runs through the named-patient import pathway coordinated with the patient's tertiary care centre in Abu Dhabi, Dubai, or Sharjah.
This guide explains the legal pathway, the documentation your physician prepares, typical timing, how quotes work, and where Reserve Meds fits in.
Ask about Oxlumo in UAE
Tell us the medicine and your country. We reply within one business day. On WhatsApp we usually reply the same day.
The clinical situation
Oxlumo is a subcutaneous small interfering RNA (siRNA) therapy that reduces hepatic oxalate production at the source, by silencing the HAO1 gene encoding glycolate oxidase. In PH1, the underlying AGXT deficiency drives oxalate overproduction, recurrent kidney stones, nephrocalcinosis, and progressive chronic kidney disease that frequently advances to end-stage renal disease and the need for combined liver-kidney transplantation. Oxlumo is indicated specifically for PH1. Dosing is weight-based, with a loading phase (monthly for three doses) followed by maintenance, monthly for young children and quarterly for larger patients per label. Eligibility is anchored in biochemical and genetic confirmation of PH1 (elevated urinary oxalate, AGXT mutations) and specialist-led management. Your physician will establish baseline urinary oxalate, creatinine, eGFR, renal imaging, and a long-term follow-up cadence.
Case active and ready to skip the regulatory walkthrough? Ask about a medicine or WhatsApp us.
Is Oxlumo legally importable into the UAE?
Yes, through the UAE Ministry of Health and Prevention (MoHAP) named-patient import framework, with parallel authority operated by the Department of Health (DoH) in Abu Dhabi and Dubai Health Authority (DHA) in Dubai depending on where the prescribing facility sits.
The named-patient mechanism permits an Emirati-licensed physician to import a medicine not locally registered when (a) it is approved by a recognised reference authority such as the US FDA, (b) no clinically equivalent locally available alternative suits the specific patient, (c) the physician accepts clinical responsibility, and (d) chain of custody is documented end-to-end. PH1 has no clinically equivalent registered alternative on the UAE formularies, which supports clinical rationale.
How the pathway works, step by step
- Consultation with your treating nephrologist or metabolic-disease specialist. AGXT genetic report, urinary oxalate measurements, and a clinical rationale letter.
- Baseline assessment. 24-hour urinary oxalate (or spot oxalate:creatinine ratio for young children), eGFR, renal ultrasound, and plasma oxalate where relevant.
- MoHAP named-patient application. The physician or hospital pharmacy files clinical rationale, patient reference, weight-based dosing plan, and chain-of-custody commitment.
- US-side sourcing. Reserve Meds coordinates with our US-licensed pharmaceutical wholesale partner to secure Oxlumo from authorised distribution under DSCSA.
- Cold-chain shipment. Oxlumo requires refrigerated handling; shipment follows validated cold-chain protocols with temperature logging.
- Arrival and administration. The hospital pharmacy releases the product; the paediatric or adult clinic administers the subcutaneous dose and schedules the next.
What documentation your physician needs
- Clinical rationale letter confirming PH1 and Oxlumo as the indicated therapy
- Verification of the UAE medical license
- AGXT genetic test result and biochemical workup (elevated urinary oxalate)
- Baseline eGFR, renal ultrasound, and plasma oxalate where relevant
- Patient weight (for weight-based dosing) and age
- Planned dosing schedule (loading + maintenance) and long-term monitoring plan
Reserve Meds provides a physician documentation kit bundling the templates MoHAP reviewers expect for ultra-rare paediatric/adult metabolic disease named-patient imports.
Costs and timing
Medicine price: quote on request. Every case gets a written custom quote before you commit. Reserve Meds provides a transparent, itemised delivered quote, covering product, cold-chain logistics, MoHAP documentation handling, customs clearance, and coordination, at the start of intake.
We give you a written timeline estimate for your case before you commit. Subsequent doses are scheduled according to the weight-based maintenance cadence.
If your clinical situation is time-sensitive, tell us at intake. We triage accordingly.
Reserve Meds's role
- Sourcing. Through our US-licensed pharmaceutical wholesale partner under DSCSA chain-of-custody.
- Documentation. Regulatory package for your physician and MoHAP / DoH / DHA review.
- Logistics. Validated cold-chain shipment to your prescribing hospital pharmacy.
- Dedicated case lead. A named point of contact coordinating long-term refills for paediatric or adult PH1 cases.
What we do not do: We are not the prescriber. We do not practise medicine. We are not the dispensing pharmacy. All clinical decisions remain with your treating nephrologist or metabolic-disease specialist.
Frequently asked
Is this legal in the UAE? Yes, when executed through the MoHAP / DoH / DHA named-patient framework with appropriate documentation. See our trust and compliance page.
How is Oxlumo different from Rivfloza? Both are siRNA therapies targeting oxalate overproduction in primary hyperoxaluria. Oxlumo is FDA-labeled specifically for PH1 across all ages. Rivfloza (nedosiran) has a different labelled population. Your specialist will select based on the genetic subtype, age, and clinical picture.
Does Oxlumo cure PH1? No disease-modifying therapy is curative in PH1, but Oxlumo substantially reduces urinary oxalate and can slow disease progression. Transplant considerations remain individualised.
Will insurance cover this? Cash-pay is the default. Some UAE private insurers consider ultra-rare paediatric imports case by case; we supply documentation for your submission but do not process insurance claims directly.
Next step
Examples and timings above are composite illustrations drawn from published sources and typical named-patient patterns. Your individual case is assessed by your physician and our clinical-regulatory team; Reserve Meds does not guarantee outcomes or timelines.
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy, not the prescriber, and not the manufacturer. Cash-pay. Export-only (US → overseas). Composite case examples. Not medical advice.
Reviewed by the Reserve Meds clinical operations team. Last reviewed: 2026-04-23.
Abu Dhabi and Dubai
This guide covers the whole UAE, including Abu Dhabi and Dubai. At federal level, medicines are regulated by the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention (MOHAP). MOHAP also issues permits to import medicines for personal use. Hospitals, clinics and doctors are licensed by the health authority of their own emirate: the Department of Health Abu Dhabi (DoH) in Abu Dhabi, and the Dubai Health Authority (DHA) in Dubai.
In practice, the hospital that treats you follows the rules of its own emirate, so the paperwork is prepared for that hospital. Tell us which hospital or doctor is treating you, in Abu Dhabi, Dubai or another emirate, and we prepare the document pack for that route.
Sources: Department of Health Abu Dhabi; Dubai Health Authority, Health Regulation Sector; MOHAP, permit to import medicines for personal use; Simmons & Simmons, UAE pharmaceutical law and the Emirates Drug Establishment.
Frequently asked questions
How can I get Oxlumo in the UAE if it is not approved or available there?
Reserve Meds coordinates US-sourced Oxlumo for patients in the UAE through a legal named-patient pathway, working with your treating doctor. Your treating physician provides the prescription and clinical justification; Reserve Meds prepares the named-patient documentation for the UAE and arranges DSCSA-compliant US sourcing and delivery to your physician or hospital pharmacy.
Can I access Oxlumo in the UAE through a named-patient import?
Often, yes. Named-patient access (sometimes called personal import) is the legal route we use for FDA-approved medicines such as Oxlumo. It is different from compassionate use, which covers investigational medicines through the manufacturer's own program; we do not supply investigational medicines. Eligibility and paperwork depend on the regulator in the UAE, and Reserve Meds maps the specific pathway for each market it coordinates.
Do I need a prescription to access Oxlumo in the UAE through Reserve Meds?
Yes. Reserve Meds is not a pharmacy and does not prescribe. A valid prescription and clinical justification from your treating physician are required, and all clinical decisions remain with your physician.
How does Reserve Meds deliver Oxlumo to a patient in the UAE?
Medicines are supplied through a US-licensed pharmaceutical wholesale partner, and Reserve Meds coordinates delivery of Oxlumo to your treating physician or hospital pharmacy in the UAE, with appropriate handling for the product.
How long does it take, and what does Oxlumo in the UAE cost through Reserve Meds?
After a short intake, the clinical team responds within one business day with case-specific feasibility, an indicative timeline, and a formal written quote. Cost depends on the destination, the prescribed regimen, and the duration of therapy, and is confirmed in writing before anything proceeds.
How do I start a request for Oxlumo in the UAE?
Submit a 60-second intake through the Reserve Meds patient portal, or message our team on WhatsApp. We reply within one business day. On WhatsApp we usually reply the same day.